Of the 81 IIM patients with anti‐CRT Ab, 52 (64.2%), 10 (12.3%) and 19 (23.5%) were classified as DM, ADM and polymyositis (immune‐mediated necrotising myopathy) (PM (IMNM)), respectively. This evidence concerns the gene CALR and dermatomyositis.